1978
Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.
Dedrick R, Myers C, Bungay P, DeVita V. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Journal Of The National Cancer Institute 1978, 62: 1-11. PMID: 626987.Peer-Reviewed Original ResearchConceptsOvarian cancerResidual ovarian cancerTreatment of patientsPharmacokinetic rationalePlasma clearancePeritoneal cavityPeritoneal spaceDrug AdministrationPharmacokinetic calculationsPeritoneal permeabilitySuch drugsCancerAnticancer drugsDrugsTreatmentHydrophilic anticancer drugPatientsAdministrationClearance
1968
Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides) A study of 196 autopsy cases∗
Roberts W, Glancy D, Devita V. Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides) A study of 196 autopsy cases∗. The American Journal Of Cardiology 1968, 22: 85-107. PMID: 4873149, DOI: 10.1016/0002-9149(68)90250-6.Peer-Reviewed Original ResearchConceptsCardiac lymphomaMalignant lymphomaHodgkin's diseaseMycosis fungoidesIncidence of dyspneaCent of patientsReticulum cell sarcomaUnderlying cardiac conditionCardiac metastasisElectrocardiographic disturbancesVentricular gallopChest painPulmonary lymphomaPrecordial murmurCardiac dysfunctionLymphomatous involvementClinical findingsCell sarcomaCardiac conditionsGross examinationLymphomaPatientsCardiac chambersFocal nodulesHistologic sections